Oklahoma Heart Hospital | Oklahoma Cardiovascular Research Group

Research site

(Unclaimed)

Location

4200 West Memorial Road Suite 510, Oklahoma CIty, Oklahoma, United States of America

Site insights

Top conditions

Top treatments

INS50589

Apixaban

carvedilol

PF-04950615

Clopidogrel

Deferiprone

RN316

Tolvaptan

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

7 of 24 total trials

Baroreflex Activation Therapy for Heart Failure (BeAT-HF)

The purpose of this clinical trial (NCT02627196) is to develop valid scientific evidence for safety and effectiveness of Baroreflex Activation Therap...

Active, not recruiting

Heart Failure

Device: BAROSTIM NEO® System

Drug: Medical Management

Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure (DRAIN-HF)

Aortix is a circulatory support device for chronic heart failure patients on medical management who have been hospitalized for acute decompensated he...

Enrolling

ADHF

Heart Failure, Diastolic

Device: Aortix System

Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial (CLASP II TR)

To establish the safety and effectiveness of the Edwards PASCAL Transcatheter Repair System in patients with symptomatic severe tricuspid regurgitati...

Enrolling

Tricuspid Valve Insufficiency

Tricuspid Valve Disease

Drug: Optimal Medical Therapy

Device: Edwards PASCAL System

PARTNER 3 Trial - Aortic Valve-in-Valve

This study will assess the safety and effectiveness of the SAPIEN 3/SAPIEN 3 Ultra transcatheter heart valve (THV) in patients with a failing aortic...

Enrolling

Aortic Stenosis, Severe

Aortic Stenosis

Device: Edwards SAPIEN 3/SAPIEN 3 Ultra THV

PARTNER 3 Trial: Safety and Effectiveness of the SAPIEN 3 Transcatheter Heart Valve in Low Risk Patients With Aortic Stenosis (P3)

To establish the safety and effectiveness of the Edwards SAPIEN 3 Transcatheter Heart Valve (THV) in patients with severe, calcific aortic stenosis w...

Active, not recruiting

Aortic Stenosis

Device: SAPIEN 3 THV

Procedure: SAVR

PARTNER II Trial: Placement of AoRTic TraNscathetER Valves II - S3 Intermediate (PII S3i)

The purpose of this trial is to determine the safety and effectiveness of the Edwards SAPIEN 3 transcatheter heart valve and delivery systems which a...

Active, not recruiting

Symptomatic Severe Aortic Stenosis

Device: TAVR

Safety and Efficacy of the SurVeil™ Drug-Coated Balloon (TRANSCEND)

To demonstrate the safety and efficacy of the SurVeil Drug-Coated Balloon (DCB) for treatment of subjects with symptomatic peripheral artery disease...

Active, not recruiting

Peripheral Vascular Disease

Femoropopliteal Artery Occlusion

Device: Surmodics SurVeil DCB

Device: Medtronic IN.PACT Admiral DCB